The Pharmaceutical Market: Morocco

Espicom Healthcare Intelligence
May 15, 2012
62 Pages - SKU: ESPI3909415
Countries covered: Morocco

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.

Specialised intelligence on OTCs, generics, biologics and biosimilars.

Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.

A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.

The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

Please Note: this is delivered as a Zip file.


Additional Information

THE PHARMACEUTICAL MARKET: MOROCCO - REVIEW

Increasing GDP and health expenditure per capita are expected to encourage drug consumption in Morocco. Real GDP growth is expected to be in single-digit figures between 2012 and 2016. The national health insurance scheme (AMO) is expected to provide substantial additional funding for the health sector. Initially aimed at salaried workers, the scheme has been expanded to cover the self-employed. The CNSS, which operates the scheme in the private sector, announced that it would be extending cover to ambulatory care, in addition to hospital treatment. A health insurance scheme for those on very low incomes (RAMED - Régime d’Assistance Médicale aux Economiquement Démuni) was expanded in December 2011. RAMED will cover an extensive range of chronic or serious conditions included in the AMO, associated outpatient care and medicines.

The Moroccan pharmaceutical sector has entered a new phase of development with the adoption of new legislation that provides a modern legal framework for the pharmaceutical sector, which aims to address some of the structural weaknesses inherent in the previous system and open up the pharmaceutical sector to foreign investment by abolishing the requirement that pharmaceutical companies be majority-owned by a pharmacist. A patent law has also been ratified, which, although not meeting all the demands of the international pharmaceutical industry, provides a much clearer legal framework regarding intellectual property rights.

The Moroccan pharmaceutical industry is represented by two major trade organisations; AMIP and MIS. More than half of the pharmaceutical companies operating in the country are owned by foreign interests, and these companies are responsible for more than half of industry turnover. Multinationals with a strong presence in the Moroccan market include GlaxoSmithKline (GSK), Pfizer, Ranbaxy and Sanofi. Hikma is also expected to increase its market penetration, following the completion of a mandatory tender offer for 30.2% of Promopharm in January 2012, increasing its stake in the company to 94.1%. Independent local manufacturers primarily operate under licence or produce generics. Leading indigenous producers include Cooper Pharma, Laprophan and Sothéma.

ENHANCED STRATEGIC INTELLIGENCE

Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
Specialised intelligence on OTCs, generics, biologics and biosimilars.
Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

HEALTHCARE STATISTICS

A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.

Related Pages:

Pharmaceutical Market Jordan

Pharmaceutical Market Saudi Arabia

More Information...

HIGHLY DETAILED REPORT CONTENT

EXECUTIVE SUMMARY
Including Espicom's at a glance strategic analysis and key data projections

MACROENVIRONMENT
Political, economic, legal and demographic analysis

EPIDEMIOLOGY
Disease burden and prevalence

HEALTHCARE
Organisation, expenditure, infrastructure, services and workforce

REGULATORY AFFAIRS
Regulatory developments and marketing registration/authorisation

PRICING & REIMBURSEMENT

DISTRIBUTION CHANNELS

MARKET ANALYSIS
Projections, product development, manufacturing and trade

COMPETITION
Trade associations, trade fairs, company intelligence and competitive strategies

OTC PHARMACEUTICALS

GENERIC PHARMACEUTICALS

BIOLOGICS & BIOSIMILARS

OPPORTUNITIES & CHALLENGES
Espicom's unique strategic analysis

DIRECTORY

METHODOLOGY & SOURCES

More Pricing reports by Espicom Healthcare Intelligence

The Worldwide Guide to Pricing & Reimbursement by Espicom Healthcare Intelligence
Provides insight into pharmaceutical pricing and reimbursement systems around the world! ...
The Pharmaceutical Market: Vietnam by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: Venezuela by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
The Pharmaceutical Market: USA by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>

 

SELECT A LICENSE

    Online Download  USD 1,085  
    Global Site License  USD 7,095  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!